End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1134 USD | +6.98% | -1.73% | -42.73% |
04-11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-13 | Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors | CI |
Business Summary
Number of employees: 12
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Vaccine Discovery and Development
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| - | - | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ralph Schiess
CEO | Chief Executive Officer | 46 | 12-14 |
Bruce Harmon
DFI | Director of Finance/CFO | 66 | 30/09/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
BRD | Director/Board Member | 62 | 02-05 |
Ajit Singh
BRD | Director/Board Member | 60 | 02-06 |
James Sapirstein
CHM | Chairman | 63 | - |
Timothy Ramdeen
BRD | Director/Board Member | 32 | 31/12/22 |
Simon Tarsh
BRD | Director/Board Member | 63 | 31/07/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 22,845,100 | 17,735,278 ( 77.63 %) | 517,399 ( 2.265 %) | 77.63 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-42.73% | 2.48M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.37% | 33.03B | |
+55.32% | 24.68B | |
-16.36% | 15.12B | |
-9.19% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- ONCO Stock
- Company Onconetix, Inc.